Evidence map›Paper›PMID 41151048›Full record

ArticleAnnals of the American Thoracic Society2026

Pulmonary vascular features on chest computed tomography differentially associate with adverse outcomes in smokers in COPDGene.

Shelsey W Johnson, Pietro Nardelli, James C Ross, Carolyn E Come, Gonzalo Sanchez-Ferrero, Carrie L Pistenmaa, Wei Wang, Alejandro A Diaz, Michael J Wells, George R Washko and 3 more

Abstract read
In one paragraph

Article in Annals of the American Thoracic Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shelsey W JohnsonDepartment of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United States.ORCID 0000-0002-6297-6389
Pietro NardelliDepartment of Radiology, Brigham and Women's Hospital, Boston, MA, United States.
James C RossDepartment of Radiology, Brigham and Women's Hospital, Boston, MA, United States.
Carolyn E ComeDepartment of Pulmonary and Critical Care Medicine, Lahey Hospital and Medical Center, Burlington, MA, United States.
Gonzalo Sanchez-FerreroDepartment of Radiology, Brigham and Women's Hospital, Boston, MA, United States.
Carrie L PistenmaaDepartment of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United States.
Wei WangDepartments of Medicine and Neurology, Brigham and Women's Hospital, Boston, MA, United States.
Alejandro A DiazDepartment of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United States.ORCID 0000-0001-5037-2919
Michael J WellsDepartment of Pulmonary and Critical Care Medicine, University of Alabama, Birmingham, AL, United States.
George R WashkoDepartment of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United States.
Rachel K PutmanDepartment of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United States.
Farbod N RahaghiDepartment of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United States.
Raúl San José EstéparDepartment of Radiology, Brigham and Women's Hospital, Boston, MA, United States.ORCID 0000-0002-3677-1996

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
GENETIC EPIDEMIOLOGY OF COPD (COPD GENE) TASK A: STUDY VISIT 4, COLLECTION OF COPDGENE STUDY DATA ANDBIOSPECIMENS AND OVERSIGHT OF THE COPDGENE STUDY75N92023D00011 · NHLBI · NATIONAL JEWISH HEALTH · PI NEWMAN, LEE S · 2023 to 2025
$29.6M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
Prognostic Markers of Emphysema ProgressionR01HL149877 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SAN JOSE ESTEPAR, RAUL · 2020 to 2023
$2.8M
The Pulmonary Vasculature and Platelets in Emphysema and COPDK23HL141651 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI PISTENMAA, CARRIE L · 2019 to 2023
$983k
Computed tomography for early detection and phenotyping of pulmonary hypertension associated with chronic obstructive pulmonary disease with implications for treatmentK23HL179493 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SHELSEY WEINSTEIN JOHNSON · 2025 to 2026
$344k
AstraZenecaIndustry Advisory CommitteeNHLBI NIH HHS 1K23HL179493-01NHLBI NIH HHS 1R01HL149877NHLBI NIH HHS 75N92023D00011NHLBI NIH HHS K23 HL141651NHLBI NIH HHS K23 HL179493NHLBI NIH HHS R01 HL149877NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897NIHNIH HHS 75N92023D00011The COPDGene study NCT00608764
6 · The paper itself

Abstract

rationaleIn smokers with and without chronic obstructive pulmonary disease (COPD), the differential strengths of association between chest computed tomography (CT)-based metrics of pulmonary vascular disease and adverse outcomes are unknown.

objectivesWe aimed to quantify the differential strengths of association of CT features, from the distal pulmonary arteries to the central great vessels and cardiac chambers, with acute respiratory exacerbations (AREs) and mortality in smokers with and without COPD.

methodsSmokers with and without COPD with pulmonary vascular morphology and outcomes data were identified in COPDGene. Negative binominal and multivariable Cox proportional hazard models were used to investigate the association of CT features, including volume of the distal pulmonary arterial vasculature or pruning (<5 mm2 normalized to total arterial blood vessel volume [aBV5/aTBV]), preacinar vessels (5-20 mm2), and pulmonary artery to aorta (PA/Ao) and right to left ventricular epicardial volume (RV/LV) ratios, with outcomes. Kaplan-Meier curves were used to describe pruning risk on mortality.

resultsA total of 3169 smokers with COPD and 2530 smokers without COPD were analyzed. Among smokers with COPD, PA/Ao was the only imaging feature significantly associated with AREs (incidence rate ratio, 1.08 [95% CI, 1.04-1.12]), even after adjusting for aBV5/aTBV. Conversely, pruning demonstrated the strongest association with mortality, even in smokers without COPD (hazard ratio, 1.22 [95% CI, 1.14-1.30] and 1.26 [95% CI, 1.11-1.42], respectively). The association of preacinar vessels with mortality in smokers with COPD and in those without COPD, but with significant emphysema on imaging (≥5%), was novel.

conclusionsPruning is significantly associated with mortality risk in smokers with and without COPD; however, PA/Ao selectively associates with AREs in COPD, even when accounting for distal vasculopathy.

Indexed as

Pulmonary ArteryPulmonary Disease, Chronic ObstructiveSmokingTomography, X-Ray ComputedAgedFemaleHumansMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesSmokerschest computed tomographyCOPDpulmonary vasculature

Identifiers

PMID41151048
PMCPMC13371049

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.